Summary
The product Masteron en 200 – IL-ME200, manufactured by ironlion-lab, underwent independent testing to verify its authenticity and potency. The sample, submitted by ironlion-lab@mailhost.work, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the concentration of Drostanolone Enanthate at 207.12 mg/ml.
The testing process began on 19 August 2024, with the sample received on 6 September 2024, and analysis completed on 9 September 2024. The results confirm the presence of the expected compound with a slightly higher concentration than the labeled 200 mg/ml claim. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: ironlion-lab
- Product Name: Masteron en 200 – IL-ME200
- Active Ingredient: Drostanolone Enanthate
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #48571
- Testing Ordered: 19 August 2024
- Sample Received: 6 September 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: ironlion-lab
- Analysis Paid For By: ironlion-lab
Testing Results
- Measured Concentration: 207.12 mg/ml (3.56% above the expected 200 mg/ml)
Verification Details
Verification URL: https://janoshik.com/tests/48571_8E1MHWUAR445
Evaluation of Manufacturer-Submitted Testing
This analysis confirms that Drostanolone Enanthate is present at 207.12 mg/ml, slightly exceeding the expected 200 mg/ml specification. While this deviation is minor, maintaining precise concentrations is crucial for consistency and consumer confidence. The test results indicate a high level of accuracy in formulation, but independent verification across multiple batches is recommended to ensure long-term reliability. Janoshik Analytical is recognized for its rigorous testing protocols, adding credibility to the findings.
Conclusion
The analysis confirms that Masteron en 200 – IL-ME200 contains 207.12 mg/ml of Drostanolone Enanthate, slightly above the labeled concentration. This slight variation does not indicate a major concern, but ongoing testing and third-party validation are encouraged to maintain quality consistency. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. While manufacturer-submitted testing can be valuable, independent verification across different batches is always recommended. Readers are encouraged to use this information responsibly.
